Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.

Cite this paper

@article{Schiffman2010OncogenicBM, title={Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.}, author={Joshua Schiffman and John Graeme Hodgson and Scott VandenBerg and Patrick J. Flaherty and Mei-Yin C. Polley and Mamie Yu and Paul G Fisher and David H . Rowitch and James M. Ford and Mitchel S. Berger and Hanlee P. Ji and David H . Gutmann and C. David James}, journal={Cancer research}, year={2010}, volume={70 2}, pages={512-9} }